---
title: "Sensome initiates trial assessing tissue microsensor technology in peripheral artery disease"
date: "2024-02-13T15:59:39.000Z"
publishedDate: "13 février 2024"
summary: "Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was designated a breakthrough medical device for use in brain arteries by the US Food and Drug Administration (FDA) in 2021."
importance: ""
sourceUrl: "https://interventionalnews.com/sensome-initiates-trial-assessing-tissue-microsensor-technology-in-peripheral-artery-disease/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2024-02-13-sensome-initiates-trial-assessing-tissue-microsensor-technology-in-peripheral-artery-disease"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2024/02/sensome-logo.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/sensome-initiates-trial-assessing-tissue-microsensor-technology-in-peripheral-artery-disease/"
---

![Sensome initiates trial assessing tissue microsensor technology in peripheral artery disease](https://interventionalnews.com/wp-content/uploads/sites/13/2024/02/sensome-logo.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/sensome-initiates-trial-assessing-tissue-microsensor-technology-in-peripheral-artery-disease/*

## L’essentiel

Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was designated a breakthrough medical device for use in brain arteries by the US Food and Drug Administration (FDA) in 2021.

## Lien source

https://interventionalnews.com/sensome-initiates-trial-assessing-tissue-microsensor-technology-in-peripheral-artery-disease/
